1CM Inc.

1CM Inc. functions as a diverse enterprise within the cannabis industry. The company's primary focus is on utilizing technology to cater to individual consumers, with the objective of making cannabis markets more accessible and inclusive. Previously known as Leviathan Natural Products Inc., the company underwent a name change to 1CM Inc. in September 2022. Its operations are headquartered in Markham, Canada.

1CM Inc. trades as EPIC.CN on CNQ. The company is classified in Healthcare / Drug Manufacturers - Specialty & Generic and reports in CAD.

The current profile places the business in Drug Manufacturers - Specialty & Generic. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $73.37M of revenue and $484,849 of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

1CM Inc. can be compared against peers such as The Cannabist Company Holdings Inc., Covalon Technologies Ltd., C21 Investments Inc., iAnthus Capital Holdings, Inc., Leef Brands Inc., MedMira Inc..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $18.84M, beta of 1.55, and return on equity of +1.7%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

EPIC.CN currently shows total debt of $3.42M and beta of 1.55. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://1cminc.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.